CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES
- Country
- France
- Type
- Beneficiary
- Website
- www.chu-nantes.fr
- Calls awarded
- 1
- Grants received
- 20
Funding record
- 20 grants on record
- €10,955,147.92 awarded in total
- 2008–2025 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
5 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- NANTES UNIVERSITE
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS
- CHARITE - UNIVERSITAETSMEDIZIN BERLIN
- STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM
- THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
- ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK
- FUNDACIO DE RECERCA CLINIC BARCELONA-INSTITUT D INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER
Calls from this organisation
Grants received
- Patient-centred, evidence-based late effect screening and follow-up care of survivors of adolescent and young adult cancer
- BRinging hEAlTH and social sciences to a new level through an interdisciplinary doctoral programme
- Long-term alterations of host-microbiome interactions and cardiovascular and respiratory diseases progression after pneumonia
- MULti-Tumour based prediction and manipulation of Immune Response
- NaV1.5 regulation fine-tuning as a therapy for cardiac Conduction and Arrhythmic diseases at Risk of suddEn Death
- An Artificially Intelligent Diagnostic Assistant for gastric inflammation
- Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia
- Reshaping undesired Inflammation in challenged Tissue Homeostasis by Next-Generation regulatory T cell (Treg) Approaches – from Advanced Technology Developments to First-in-Human Trials
- Personalised maxillofacial bone regeneration
- The EUropean TRAnsplantation and INnovation (EU-TRAIN) consortium for improving diagnosis and risk stratification in kidney transplant patients
- REgenerative therapy of intervertebral disc: a double blind phase 2b trial of intradiscal injection of mesenchymal stromal cells in degenerative disc disease of the lomber SPINE unresponsive to conventional therapy
- Non-invasive monitoring of perinatal health through multiparametric digital representation of clinically relevant functions for improving clinical intervention in neonatal units (Digi-NewB)
- A multi-center randomized, placebo-controlled trial of mirabegron, a new beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease
- Defining the role of xeno-directed and autoimmune events in patients receiving animal-derived bioprosthetic heart valves
- Personalized minimization of immunosuppression after solid organ transplantation by biomarker-driven stratification of patients to improve long-term outcome and health-economic data of transplantation
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Source: BOAMP — Direction de l’information légale et administrative (DILA).
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.